Daisuke Kotani

4.3k citations
117 papers · 2.1k · 1 hit paper · h-index 19

Impact in

Papers in

    • Colorectal Cancer Treatments and Studies 55
    • Cancer Immunotherapy and Biomarkers 19
    • Colorectal Cancer Surgical Treatments 15
    • Gastric Cancer Management and Outcomes 22
    • Lung Cancer Treatments and Mutations 15

Daisuke Kotani

104 papers receiving 2.1k citations

Daisuke Kotani's Hit Papers

Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer: An Open-Label, Dose-Escalation, and Dose-Expansion Phase Ib Trial (REGONIVO, EPOC1603) 2020 · 595 citations
5950+2+4Years since publication100200300400500

Peers

Daisuke Kotani
Comparison fields: 5 of 74
  • Oncology 1.2k
  • Pathology and Forensic Medicine 406
  • Cancer Research 334
  • Gastroenterology 110
  • Pulmonary and Respiratory Medicine 494
Replace Yoonjin Kwak with:
Yoonjin Kwak South Korea
Hans‐Michael Behrens Germany
Naoki Takahashi Japan
Dorothy W. Pan United States
Christine Lagorce France
Zanete Zvirbule Latvia
Raija Ristamäki Finland
Ralph H. Hruban United States
Yoichiro Yamanaka United States
Pascal Hammel France
Daisuke Kotani relative to Yoonjin Kwak South Korea Yoonjin Kwak's profile →
Citations per field
00.5×1.5×2.4×
Yoonjin Kwak · 1×
Citations per year

Countries citing papers authored by Daisuke Kotani

Since Specialization
Citations

This map shows the geographic impact of Daisuke Kotani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daisuke Kotani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daisuke Kotani more than expected).

Fields of papers citing papers by Daisuke Kotani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daisuke Kotani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daisuke Kotani. The network helps show where Daisuke Kotani may publish in the future.

Co-authors

The 25 scholars most cited alongside Daisuke Kotani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daisuke Kotani Line = papers co-authored together Daisuke Kotani links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 117 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer: An Open-Label, Dose-Escalation, and Dose-Expansion Phase Ib Trial (REGONIVO, EPOC1603)
Hit paper breakdown →
2020595
2 2018160
3 2019114
4 2023101
5 202197
6 201987
7 202180
8 201960
9 201658
10 202055
11 202047
12 202142
13 202241
14 202041
15 202141
16 202033
17 201932
18 202126
19 202122
20 202217

About Daisuke Kotani

Daisuke Kotani is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Surgery and Pathology and Forensic Medicine, having authored 117 papers that have together received 2.1k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (55 papers), Cancer Genomics and Diagnostics (24 papers), Genetic factors in colorectal cancer (22 papers), Gastric Cancer Management and Outcomes (22 papers), Cancer Immunotherapy and Biomarkers (19 papers), Esophageal Cancer Research and Treatment (17 papers), Colorectal Cancer Surgical Treatments (15 papers) and Lung Cancer Treatments and Mutations (15 papers). The work is most often cited by research in Oncology (1.2k citations), Pathology and Forensic Medicine (406 citations), Cancer Research (334 citations), Gastroenterology (110 citations) and Pulmonary and Respiratory Medicine (494 citations). Daisuke Kotani has collaborated with scholars based in Japan, United States and Taiwan. Frequent co-authors include Kohei Shitara, Akihito Kawazoe, Takashi Kojima, Takeshi Kuwata, Takayuki Yoshino, Hiroyoshi Nishikawa, Yosuke Togashi, Masashi Wakabayashi, Akihiro Sato and Yoshiaki Nakamura. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical Cancer Research, BMC Cancer and Cancer Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact